title: Activity of polymorphonuclear (PMN) leukocytes during bovine herpes virus-1 induced respiratory disease: effect of recombinant bovine interferon alpha I1.
abstract: Following infection of cattle with bovine herpes virus-1 there is a state of generalized immunosuppression involving various leukocytes including polymorphonuclear (PMN) leukocytes. Since the PMN is considered to be pivotal in recovery from secondary bacterial infections during bovine respiratory disease, investigations were initiated to determine PMN activity in this disease and whether interferon could modulate PMN activity. In this study, the in vivo administration of recombinant interferon alpha-I1 was shown to increase PMN functions as measured by migration/chemotaxis and generation of reactive oxygen species. This augmented activity of PMN appeared to correlate with the reduction of overall clinical disease, that is, number of sick days, lung lesions and weight loss. In the study administration of interferon by the intranasal or intramuscular route were as effective in stimulating PMN function. Based on these studies it was concluded that the reason for improved performance of calves treated with interferon would be due to its immunomodulatory effects on leukocytes. Although interferon did not alter the initial suppression of PMN functions, these functions returned to normal and exceeded normal activities by 7-9 days post-infection, the time when maximal bacterial activity normally is present.
authors.affiliation: Veterinary Infectious Disease Organization, Saskatoon, Saskatchewan, Canada.
authors.forename: M J
authors.initials: MJ
authors.lastname: Lawman
authors.forename: G
authors.initials: G
authors.lastname: Gifford
authors.forename: M
authors.initials: M
authors.lastname: Gyongyossy-Issa
authors.forename: R
authors.initials: R
authors.lastname: Dragan
authors.forename: J
authors.initials: J
authors.lastname: Heise
authors.forename: L A
authors.initials: LA
authors.lastname: Babiuk
mesh_terms: D000818:Animals; D002417:Cattle; D002465:Cell Movement; D002634:Chemotaxis, Leukocyte; D005609:Free Radicals; D007165:Immunosuppression Therapy; D007167:Immunotherapy; D066298:In Vitro Techniques; D007241:Infectious Bovine Rhinotracheitis / Q000276:immunology / Q000628:therapy*; D007370:Interferon Type I / Q000627:therapeutic use*; D009504:Neutrophils / Q000276:immunology* / Q000502:physiology; D010100:Oxygen / Q000378:metabolism; D010587:Phagocytosis; D013997:Time Factors
chemical_list: D005609:Free Radicals; D007370:Interferon Type I; D010100:Oxygen